NANJING KING-FRIEND FDA Approval Nov. 19, 2024, 05:11 UTC 61 0 comments FDA approve CYANOCOBALAMIN Comment Full text
SYNDAX PHARMACEUTICALS INC FDA Approval Nov. 18, 2024, 14:30 UTC 46 0 comments FDA approve REVUMENIB Comment Full text
ACTAVIS MID ATLANTIC FDA Approval Nov. 18, 2024, 09:58 UTC 43 0 comments FDA approve DICLOFENAC SODIUM Comment Full text
SOMERSET THERAPS LLC FDA Approval Nov. 18, 2024, 09:58 UTC 45 0 comments FDA approve MOXIFLOXACIN HYDROCHLORIDE Comment Full text
INGENUS PHARMS LLC FDA Approval Nov. 18, 2024, 09:58 UTC 42 0 comments FDA approve METAXALONE Comment Full text
NORVIUM BIOSCIENCE FDA Approval Nov. 18, 2024, 09:58 UTC 36 0 comments FDA approve CITALOPRAM HYDROBROMIDE Comment Full text
HIKMA FDA Approval Nov. 18, 2024, 09:58 UTC 40 0 comments FDA approve ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE Comment Full text
WANBANG BIOPHARMS FDA Approval Nov. 18, 2024, 09:58 UTC 38 0 comments FDA approve CARISOPRODOL Comment Full text
STRIDES PHARMA FDA Approval Nov. 18, 2024, 09:58 UTC 36 0 comments FDA approve EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE Comment Full text
FRESENIUS KABI USA FDA Approval Nov. 18, 2024, 09:58 UTC 32 0 comments FDA approve THIAMINE HYDROCHLORIDE Comment Full text